At Decoy, we are engineering the next generation of peptide conjugate therapies to protect and expand patient lives.
Our Platform applies AI/ML for rapid design of therapeutics and uses world-leading fast and scalable manufacturing with our proprietary “single-shot” synthesis technology. Our current focus areas include engineering a new class of broad-acting antivirals, a single drug for multiple pathogens, and GPCR-targeting peptide drug conjugates to treat GI tumors.
We believe in developing medicines that are accessible and affordable to everyone, everywhere—empowering communities worldwide to lead healthier lives.
Connect with us, and learn more at https://decoytx.com/.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 1 Broadway, Cambridge,massachusetts 02142,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://decoytx.com/
- Keywords
- Normunity.
- HQ
- CAMBRIDGE, Massachusetts
Decoy Therapeutics Inc. Questions
Decoy Therapeutics Inc.'s website is https://decoytx.com/
Decoy Therapeutics Inc.'s LinkedIn profile is https://www.linkedin.com/company/decoy-therapeutics-inc
Decoy Therapeutics Inc. has
14 employees.
View email and phone details for 14
employees at Decoy Therapeutics Inc..
Decoy Therapeutics Inc.'s industry is
Biotechnology Research
Decoy Therapeutics Inc.'s top competitors are
Kardigan,
Scorpion Therapeutics,
Akimbo Health,
Normunity,
Timberlyne Therapeutics,
Umoja Biopharma,
Micron Biomedical,
Salarius Pharmaceuticals,
Regenxbio,
Immunovant.
Decoy Therapeutics Inc.'s categories are Biotechnology Research
Decoy Therapeutics Inc.'s founding year is 2020
